Echo IQ is trading at A$0.60, a -10.45% change, with no new company-specific announcement or clear catalyst identified for September 25, 2026.

  • It closed at A$0.67 on September 24, 2026.
  • The latest material disclosure remains the September 17 EchoSolv HF FDA update, which described a potential regulatory path forward but does not directly explain the decline.
  • Broader market indicators were largely flat, leaving a global-market explanation unconfirmed.